Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

JMJD1B Inhibitors

The chemical class termed JMJD1B inhibitors comprises a diverse group of compounds intricately designed to modulate the activity of Jumonji domain-containing protein 1B (JMJD1B), a histone demethylase enzyme responsible for catalyzing the removal of methyl groups from histones. These inhibitors are meticulously developed through a combination of structural insights and mechanistic studies, often utilizing advanced techniques such as computational modeling, high-throughput screening, and chemical synthesis. The central objective is to engineer compounds with the precise capability to selectively interact with JMJD1B, potentially affecting its role in epigenetic regulation and gene expression.

By targeting JMJD1B, these inhibitors serve as invaluable tools for probing the intricate processes of histone modification and chromatin dynamics, offering insights into the complex mechanisms that underlie gene regulation. The exploration of JMJD1B inhibitors contributes to a deeper understanding of the nuanced interplay between epigenetic modifications and gene expression, unveiling insights into the multifaceted orchestration of cellular functions.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

GSK-J4

1373423-53-0sc-507551
100 mg
$1275.00
(0)

A small molecule inhibitor that has been studied for its potential inhibitory effects on JMJD1B, offering insights into its role in epigenetic regulation.

SP2509

1423715-09-6sc-492604
5 mg
$284.00
(0)

This compound has been explored for its effects on JMJD1B activity and its potential implications for epigenetic control.

TC-E 5003

17328-16-4sc-397056
50 mg
$151.00
3
(0)

An experimental inhibitor that targets JMJD1B, TC-E 5003 has been studied for its effects on histone demethylation and gene expression.

Methylstat

1310877-95-2sc-507374
10 mg
$480.00
(0)

This compound has been investigated for its potential to inhibit JMJD1B and modulate histone methylation patterns.

JIB 04

199596-05-9sc-397040
20 mg
$177.00
(0)

An inhibitor that targets multiple Jumonji-domain histone demethylases, including JMJD1B, JIB-04 has been explored for its effects on epigenetic regulation.

OG-L002

1357302-64-7sc-478221
5 mg
$270.00
(0)

This compound has been studied for its potential inhibitory effects on JMJD1B and its role in modulating gene expression.

GSK J1

1373422-53-7sc-391113
sc-391113A
10 mg
50 mg
$193.00
$813.00
(0)

A derivative of GSK-J4, GSK-J1 has also been investigated for its potential to inhibit JMJD1B and influence epigenetic processes.